CDKV Holdings’s Albemarle ALB Stock Holding History

CDKV Holdings’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38K	Hold	25	–	–	﹤0.01%	245
2026 Q1	$4.49K	Hold	25	–	–	﹤0.01%	236
2025 Q4	$3.54K	Buy	+25	New	+$2.84K	﹤0.01%	246

Other funds holding ALB

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

CDKV Holdings's ALB Position: Q2 2026 in Review

CDKV Holdings held its Albemarle (ALB) position steady in Q2 2026 at 25 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #245.

CDKV Holdings first reported a position in ALB in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.49K in Q1 2026. 937 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

CDKV Holdings held 25 shares of Albemarle worth $3.38K as of Q2 2026.
CDKV Holdings left its Albemarle share count unchanged in Q2 2026.
Albemarle made up ﹤0.01% of CDKV Holdings's portfolio in Q2 2026, its #245 holding.
CDKV Holdings first reported a position in Albemarle in Q4 2025 and has held it in 3 quarters since.
CDKV Holdings's Albemarle position peaked at $4.49K in Q1 2026.
937 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.